RhumbLine Advisers’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.19M | Buy |
96,327
+78
| +0.1% | +$3.3K | ﹤0.01% | 1622 |
|
|
2025
Q4 | $4.46M | Sell |
96,249
-8,476
| -8% | -$355K | ﹤0.01% | 1461 |
|
|
2025
Q3 | $3.66M | Sell |
104,725
-4,327
| -4% | -$150K | ﹤0.01% | 1584 |
|
|
2025
Q2 | $3.22M | Sell |
109,052
-2,576
| -2% | -$73.5K | ﹤0.01% | 1635 |
|
|
2025
Q1 | $3.33M | Buy |
111,628
+3,400
| +3% | +$104K | ﹤0.01% | 1562 |
|
|
2024
Q4 | $3.1M | Buy |
108,228
+5,920
| +6% | +$196K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $3.95M | Sell |
102,308
-5,056
| -5% | -$180K | ﹤0.01% | 1545 |
|
|
2024
Q2 | $3.46M | Buy |
107,364
+2,966
| +3% | +$103K | ﹤0.01% | 1601 |
|
|
2024
Q1 | $4.05M | Sell |
104,398
-3,749
| -3% | -$131K | ﹤0.01% | 1523 |
|
|
2023
Q4 | $3.33M | Sell |
108,147
-1,835
| -2% | -$46K | ﹤0.01% | 1640 |
|
|
2023
Q3 | $2.46M | Buy |
109,982
+988
| +0.9% | +$22.5K | ﹤0.01% | 1757 |
|
|
2023
Q2 | $2.34M | Buy |
108,994
+6,513
| +6% | +$148K | ﹤0.01% | 1809 |
|
|
2023
Q1 | $2.46M | Buy |
102,481
+7,185
| +8% | +$191K | ﹤0.01% | 1704 |
|
|
2022
Q4 | $2.21M | Buy |
95,296
+189
| +0.2% | +$3.81K | ﹤0.01% | 1731 |
|
|
2022
Q3 | $1.52M | Buy |
95,107
+1,750
| +2% | +$30.9K | ﹤0.01% | 1918 |
|
|
2022
Q2 | $1.65M | Sell |
93,357
-2,867
| -3% | -$48.2K | ﹤0.01% | 1870 |
|
|
2022
Q1 | $1.96M | Buy |
96,224
+5,509
| +6% | +$104K | ﹤0.01% | 1827 |
|
|
2021
Q4 | $1.7M | Buy |
90,715
+1,159
| +1% | +$22.6K | ﹤0.01% | 1972 |
|
|
2021
Q3 | $1.77M | Sell |
89,556
-11,495
| -11% | -$249K | ﹤0.01% | 1977 |
|
|
2021
Q2 | $2.39M | Sell |
101,051
-3,336
| -3% | -$77.1K | ﹤0.01% | 1869 |
|
|
2021
Q1 | $2.47M | Buy |
104,387
+56,692
| +119% | +$1.35M | ﹤0.01% | 1812 |
|
|
2020
Q4 | $955K | Sell |
47,695
-81
| -0.2% | -$1.58K | ﹤0.01% | 2153 |
|
|
2020
Q3 | $995K | Sell |
47,776
-8,523
| -15% | -$154K | ﹤0.01% | 1999 |
|
|
2020
Q2 | $985K | Buy |
56,299
+8,990
| +19% | +$176K | ﹤0.01% | 2054 |
|
|
2020
Q1 | $773K | Buy |
47,309
+1,746
| +4% | +$36K | ﹤0.01% | 1995 |
|
|
2019
Q4 | $938K | Buy |
45,563
+943
| +2% | +$15.7K | ﹤0.01% | 2111 |
|
|
2019
Q3 | $512K | Buy |
44,620
+706
| +2% | +$8.06K | ﹤0.01% | 2314 |
|
|
2019
Q2 | $577K | Buy |
43,914
+5,432
| +14% | +$72.6K | ﹤0.01% | 2303 |
|
|
2019
Q1 | $583K | Sell |
38,482
-536
| -1% | -$8.59K | ﹤0.01% | 2258 |
|
|
2018
Q4 | $670K | Buy |
39,018
+12,477
| +47% | +$213K | ﹤0.01% | 2163 |
|
|
2018
Q3 | $391K | Sell |
26,541
-1,800
| -6% | -$31.9K | ﹤0.01% | 2374 |
|
|
2018
Q2 | $676K | Buy |
28,341
+2,916
| +11% | +$71.7K | ﹤0.01% | 2179 |
|
|
2018
Q1 | $650K | Buy |
25,425
+242
| +1% | +$5.77K | ﹤0.01% | 2113 |
|
|
2017
Q4 | $465K | Sell |
25,183
-2,450
| -9% | -$35.1K | ﹤0.01% | 2260 |
|
|
2017
Q3 | $290K | Buy |
27,633
+230
| +0.8% | +$2.54K | ﹤0.01% | 2565 |
|
|
2017
Q2 | $343K | Buy |
27,403
+9,724
| +55% | +$96.1K | ﹤0.01% | 2488 |
|
|
2017
Q1 | $178K | Buy |
17,679
+2,568
| +17% | +$38.2K | ﹤0.01% | 2680 |
|
|
2016
Q4 | $235K | Buy |
15,111
+2,861
| +23% | +$47.5K | ﹤0.01% | 2606 |
|
|
2016
Q3 | $236K | Buy |
12,250
+200
| +2% | +$2.38K | ﹤0.01% | 2599 |
|
|
2016
Q2 | $143K | Buy |
+12,050
| New | +$199K | ﹤0.01% | 2842 |
|
Other funds holding COLL
EAM
VCM
